Healthcare provider profile · identity verified

Bart R Combs, MD

Internal Medicine · BIRMINGHAM, AL · NPI 1255374914

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	360	112
Atorvastatin Calcium	Atorvastatin Calcium	336	101
Gabapentin	Gabapentin	328	98
Losartan Potassium	Losartan Potassium	256	82
Metformin Hcl	Metformin Hcl	222	74
Pantoprazole Sodium	Pantoprazole Sodium	170	55
Metoprolol Succinate	Metoprolol Succinate	158	51
Clopidogrel	Clopidogrel Bisulfate	145	40
Tamsulosin Hcl	Tamsulosin Hcl	134	44
Omeprazole	Omeprazole	131	39
Rosuvastatin Calcium	Rosuvastatin Calcium	125	40
Pravastatin Sodium	Pravastatin Sodium	121	33
Fluticasone Propionate	Fluticasone Propionate	118	45
Metformin Hcl Er	Metformin Hcl	106	34
Lisinopril	Lisinopril	105	37
Carvedilol	Carvedilol	103	34
Furosemide	Furosemide	95	30
Levothyroxine Sodium	Levothyroxine Sodium	92	32
Hydrochlorothiazide	Hydrochlorothiazide	91	23
Prednisone	Prednisone	90	37
Allopurinol	Allopurinol	88	27
Xarelto	Rivaroxaban	84	19
Baclofen	Baclofen	83	26
Albuterol Sulfate Hfa	Albuterol Sulfate	78	33
Eliquis	Apixaban	78	22
Nortriptyline Hcl	Nortriptyline Hcl	78	22
Jardiance	Empagliflozin	75	19
Tramadol Hcl	Tramadol Hcl	73	14
Trazodone Hcl	Trazodone Hcl	71	20
Alendronate Sodium	Alendronate Sodium	67	18
Chlorthalidone	Chlorthalidone	65	23
Clonazepam	Clonazepam	65	11
Famotidine	Famotidine	65	25
Spironolactone	Spironolactone	63	24
Montelukast Sodium	Montelukast Sodium	62	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	13
Potassium Chloride	Potassium Chloride	60	18
Bupropion Xl	Bupropion Hcl	59	17
Escitalopram Oxalate	Escitalopram Oxalate	55	14
Duloxetine Hcl	Duloxetine Hcl	53	19
Trulicity	Dulaglutide	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Januvia	Sitagliptin Phosphate	47	12
Clonidine Hcl	Clonidine Hcl	46	15
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	44	16
Simvastatin	Simvastatin	44	15
Hydralazine Hcl	Hydralazine Hcl	42	14
Mirtazapine	Mirtazapine	42	15
Sertraline Hcl	Sertraline Hcl	42	17
Bupropion Hcl Sr	Bupropion Hcl	41	18
Methocarbamol	Methocarbamol	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	11
Venlafaxine Hcl Er	Venlafaxine Hcl	38	12
Glimepiride	Glimepiride	37	13
Bisoprolol Fumarate	Bisoprolol Fumarate	35	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	11
Ozempic	Semaglutide	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	13
Pregabalin	Pregabalin	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	13
Wixela Inhub	Fluticasone Propion/Salmeterol	27	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Naproxen	Naproxen	24	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	20
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Fluconazole	Fluconazole	20	12
Humulin N Kwikpen	Insulin Nph Human Isophane	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Naltrexone Hcl	Naltrexone Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Finasteride	Finasteride	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Colchicine	Colchicine	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Nystatin	Nystatin	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Lactulose	Lactulose	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clonidine	Clonidine	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error